numares GROUP Corporation

21 Drydock Avenue
Suite 21-330W
Boston,  MA  02210

United States
  • Booth: 956


Based on its proprietary Magnetic Group Signalling® (MGS®) technology numares has pushed NMR to a novel performance level. Beside the genome and proteome, the metabolome contains the most important diagnostic information on a patient’s health. Using this effectively in medicine is the goal of numares. Based on the approach to collect and to process metabolic data in their entirety, numares enables the development of integrated test systems for human diagnostics and clinical research.